Search Results

You are looking at 1 - 1 of 1 items for :

  • "oclacitinib" x
  • Book Reviews x
  • Refine by Access: All Content x
Clear All

, contrary to FDA-approved labeling, it is recommended that long-term use of oclacitinib be avoided because of an increase in the risk for adverse effects. Furthermore, several sections recommend the administration of fluralaner at 30- to 60-day intervals for

Full access
in Journal of the American Veterinary Medical Association